Remove 2004 Remove Labelling Remove Pharmaceutical Companies
article thumbnail

Speaking of Medicine – Mid-Year OPDP Enforcement Review

Eye on FDA

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

However, as with drugs, dietary supplements require evidence that they are safe and that claims on product labels are truthful and not misleading. 10 Directive 2004/24/EC introduced a registration scheme for traditional herbal medicines and requires herbal remedies sold over the counter in the UK to be registered. 2012/1916).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Following its patent expiry, Cipro’s sales in the year 2004 declined by 12.9%

article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

This year, Novartis has secured the top position with a market cap of $207.65B, followed by Bayer and Lantheus Medical Imaging PharmaShots has compiled a list of the Top 20 Radiopharma Companies developing products as a treatment option, ranked based on their market cap.

Dosage 56
article thumbnail

Thyroid Antibodies Part 2: Mechanisms to Reduce Thyroid Antibodies

The Thyroid Pharmacist

I really wish that this supplement would come back, and it’s one of the drug entities I would like to create if I ever win the lottery and start my own pharmaceutical company. 2004-0395 [36] Mutlu HH, Mutlu HH. J Clin Endocrinol Metab. 2008 Jul;93(7):2559-65. doi: 10.1210/jc.2007-2404. 2007-2404. [35] 35] Kershaw EE, Flier JS.

Immunity 105